Search results
Medicare Advantage cuts coming this year, retirement specialist warns
Newsweek· 10 hours agoA retirement specialist is warning seniors to prepare now as Medicare Advantage cuts are likely to...
Medicare patients unable to get Alzheimer's drug sparks backlash
Newsweek· 16 hours agoAlzheimer's is an incurable disease that affects roughly 6.7 million Americans. In recent years,...
Medicare Advantage Plans To Be Squeezed Next Year, Reduce Benefits
Forbes· 1 day agoMedicare Advantage plans are popular. There could be significant modifications to existing Advantage...
Retired NYC teachers toss out union prez’s crew in furor over Medicare coverage
NY Post via Yahoo News· 1 day agoRetired city educators furious over proposed changes to their health care have toppled a union slate...
Can a Jury Consider a Plaintiff’s Medicare Coverage in Evaluating Future Medical Damages Claims? |...
JD Supra· 23 hours agoCan a Jury consider a Plaintiff’s medicare coverage in evaluating future medical damages claims? California Courts generally apply the Collateral Source ...
Lost chances to treat overdose survivors are documented in new Medicare study
PAHomePage.com· 15 hours agoA new study documents lost opportunities to treat drug overdose survivors covered by the Medicare...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
San Jose Mercury News· 4 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
How A Small Singapore Biotech Found A Place Among Industry Giants
Forbes· 1 day ago“I made three promises,” Lucence’s chairman and CEO recalls from his Singapore office at an...
Medicare headquarters closed after bacteria that cause Legionnaire’s disease found in pipes
The Independent via Yahoo News· 4 days agoThe centers provides oversight of the Medicare program, the federal part of the Medicaid program,...
Medicare sets $950 price for Renalytix kidney test By Investing.com
Investing.com· 4 days agoRenalytix plc (NASDAQ: RNLX) (LSE: RENX), an AI-enabled in-vitro diagnostics company, announced that...